Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema

PURPOSE: Intravitreal anti-vascular endothelial growth factor (VEGF) therapy is the mainstay in the management of center-involving diabetic macular edema (CI-DME). Topical nonsteroidal anti-inflammatory drugs (NSAIDs) have been used to treat CI-DME as well. Whether there is any benefit of using both...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Sashwanthi, Chawla, Gajendra, Surya, Janani, Raman, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725128/
https://www.ncbi.nlm.nih.gov/pubmed/34708787
http://dx.doi.org/10.4103/ijo.IJO_1465_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725128/
https://www.ncbi.nlm.nih.gov/pubmed/34708787
http://dx.doi.org/10.4103/ijo.IJO_1465_21

Ejemplares similares